These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N, Osman-Malik Y, Frinak S, Besarab A. Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [Abstract] [Full Text] [Related]
5. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients. Mahdavi MR, Makhlough A, Kosaryan M, Roshan P. Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676 [Abstract] [Full Text] [Related]
12. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis]. Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G. Pediatr Med Chir; 1991 Oct; 13(5):475-7. PubMed ID: 1788107 [Abstract] [Full Text] [Related]
15. The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents. Malovrh M, Hojs N, Premru V. Artif Organs; 2011 Jan; 35(1):63-8. PubMed ID: 20618233 [Abstract] [Full Text] [Related]
16. Association of serum leptin with anemia in maintenance hemodialysis patients. Nasri H. Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):521-5. PubMed ID: 17186687 [Abstract] [Full Text] [Related]
17. [Iron replacement in hemodialysis patients with a normal serum ferritin level]. Riedel MK, Morgenstern T. Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155 [Abstract] [Full Text] [Related]